As of 2025-05-21, the Relative Valuation of bluebird bio Inc (BLUE) is (519.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.98 USD, the upside of bluebird bio Inc based on Relative Valuation is -10530.2%.
The range of the Relative Valuation is (446.03) - (562.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 22.9x | 19.8x |
| Forward P/E multiples | 18.1x - 26.7x | 22.4x |
| Fair Price | (446.03) - (562.57) | (519.42) |
| Upside | -9056.4% - -11396.7% | -10530.2% |
| Date | P/E |
| 2025-05-14 | -0.20 |
| 2025-05-13 | -0.13 |
| 2025-05-12 | -0.13 |
| 2025-05-09 | -0.14 |
| 2025-05-08 | -0.15 |
| 2025-05-07 | -0.15 |
| 2025-05-06 | -0.16 |
| 2025-05-05 | -0.16 |
| 2025-05-02 | -0.16 |
| 2025-05-01 | -0.16 |
| 2025-04-30 | -0.17 |
| 2025-04-29 | -0.17 |
| 2025-04-28 | -0.17 |
| 2025-04-25 | -0.17 |
| 2025-04-24 | -0.17 |
| 2025-04-23 | -0.17 |
| 2025-04-22 | -0.18 |
| 2025-04-21 | -0.16 |
| 2025-04-17 | -0.17 |
| 2025-04-16 | -0.17 |
| 2025-04-15 | -0.18 |
| 2025-04-14 | -0.19 |
| 2025-04-11 | -0.21 |
| 2025-04-10 | -0.19 |
| 2025-04-09 | -0.20 |
| 2025-04-08 | -0.20 |
| 2025-04-07 | -0.19 |
| 2025-04-04 | -0.20 |
| 2025-04-03 | -0.20 |
| 2025-04-02 | -0.20 |
| 2025-04-01 | -0.21 |
| 2025-03-31 | -0.20 |
| 2025-03-28 | -0.17 |
| 2025-03-27 | -0.15 |
| 2025-03-26 | -0.15 |
| 2025-03-25 | -0.16 |
| 2025-03-24 | -0.16 |
| 2025-03-21 | -0.16 |
| 2025-03-20 | -0.16 |
| 2025-03-19 | -0.16 |
| 2025-03-18 | -0.16 |
| 2025-03-17 | -0.16 |
| 2025-03-14 | -0.15 |
| 2025-03-13 | -0.15 |
| 2025-03-12 | -0.16 |
| 2025-03-11 | -0.16 |
| 2025-03-10 | -0.16 |
| 2025-03-07 | -0.16 |
| 2025-03-06 | -0.17 |
| 2025-03-05 | -0.16 |